ISSOIRE, France–(BUSINESS WIRE)–Regulatory News: BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, announced today that they have received 510(K) clearance from the U.S. Food & Drug Administration (FDA) to market Mallya, its smart medical device that connects insulin pens. Eric Dessertenne, CEO […]
The post BIOCORP Obtains 510(k) FDA Clearance for Mallya® appeared first on The Black Chronicle.
